Your browser doesn't support javascript.
loading
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.
Rahal, S; Boher, J M; Extra, J M; Tarpin, C; Charafe-Jauffret, E; Lambaudie, E; Sabatier, R; Thomassin-Piana, J; Tallet, A; Resbeut, M; Houvenaeghel, G; Laborde, L; Bertucci, F; Viens, P; Gonçalves, A.
Affiliation
  • Rahal S; Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd. Sainte-Marguerite, 13009, Marseille, France. rahalsoraya@hotmail.com.
  • Boher JM; Department of Biostatistics, Institut Paoli-Calmettes, Marseille, France. boherjm@ipc.unicancer.fr.
  • Extra JM; Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France. boherjm@ipc.unicancer.fr.
  • Tarpin C; Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd. Sainte-Marguerite, 13009, Marseille, France. extrajm@ipc.unicancer.fr.
  • Charafe-Jauffret E; Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France. extrajm@ipc.unicancer.fr.
  • Lambaudie E; Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd. Sainte-Marguerite, 13009, Marseille, France. tarpinc@ipc.unicancer.fr.
  • Sabatier R; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France. jauffrete@ipc.unicancer.fr.
  • Thomassin-Piana J; Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France. jauffrete@ipc.unicancer.fr.
  • Tallet A; Aix-Marseille University, Marseille, France. jauffrete@ipc.unicancer.fr.
  • Resbeut M; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France. lambaudiee@ipc.unicancer.fr.
  • Houvenaeghel G; Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France. lambaudiee@ipc.unicancer.fr.
  • Laborde L; Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd. Sainte-Marguerite, 13009, Marseille, France. sabatierr@ipc.unicancer.fr.
  • Bertucci F; Centre de Recherche en Cancérologie de Marseille, U1068 INSERM, U7258 CNRS, Marseille, France. sabatierr@ipc.unicancer.fr.
  • Viens P; Aix-Marseille University, Marseille, France. sabatierr@ipc.unicancer.fr.
  • Gonçalves A; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France. THOMASSINJ@ipc.unicancer.fr.
BMC Cancer ; 15: 697, 2015 Oct 14.
Article in En | MEDLINE | ID: mdl-26466893
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2015 Type: Article